Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography Among Patients With Acute Coronary Syndrome

Acute Coronary Syndrome Clinical Trial

Official title:

Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography (TTE) Among Patients With Acute Coronary Syndrome in Intensive Cardiac Care Unit.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01863524
• Other study ID #: emc130152ctil
• Status: Completed
• Phase: N/A
• First received: May 14, 2013
• Last updated: December 5, 2016
• Start date: May 2013
• Est. completion date: July 2015

Study information

• Verified date: December 2016
• Source: HaEmek Medical Center, Israel
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The prevalence of Abdominal Aortic Aneurysm among 65 years old individuals worldwide is 1-2%. when diagnosis is confirmed by abdominal Ultrasound the prevalence is 5.5% in men and 1% in women.

As abdominal aortic aneurysm and coronary heart disease share common risk factors, patients with acute coronary syndrome represent a high risk population in which screening for another atherosclerotic site is recommended.

Patients admitted for ACS undergo routinely TTE. during the same study, TTE may offer the opportunity to evaluate the cardiac morphology and function and to screen for Abdominal Aortic aneurysm. It was reported by different studies that the Sensitivity of this technique was between 91-96% for AAA screening.

In addition, this method is cheap, available and requires only 2-3 minutes to be added to the standard TTE.

we plan to examine patients admitted with ACS in our Intensive Care Unit for screening AAA by TTE in subcostal views in addition to the standard TTE examination.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: July 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years to 100 Years

Eligibility

Inclusion Criteria:

• patients over 65 years old with ACS. patients capable of reading, understanding and signing informed concent

Exclusion Criteria:

• suboptimal TTE windows

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal
• Syndrome

Locations

Country	Name	City	State
Israel	HaEmek MC Cardiology depratment	Afula
Israel	Haemek Medical Center	Afula

Sponsors (1)

Lead Sponsor	Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Abdominal aortic diameter measurement of 30 mm or more by portable transthoracic echocardiography, will be defined as abdominal aortic aneurysm.		Average time period of 72 hours.	No